Interventional Radiology Imaging

What Imaging Should You Order for a New Dialysis Fistula That Fails to Mature?

·
What Imaging Should You Order for a New Dialysis Fistula That Fails to Mature?

A 68-year-old man with end-stage renal disease is in your clinic for follow-up, eight weeks after creation of a left radiocephalic arteriovenous fistula (AVF). On physical exam, the fistula lacks a palpable thrill and is not sufficiently dilated for cannulation. The surgical team has referred him for an imaging workup to identify the cause of this maturation failure and to guide potential endovascular intervention. You need to determine the most appropriate initial imaging study to delineate the anatomy and pinpoint the problem. This clinical workflow article addresses this specific scenario: failure of an AVF to mature within two months. According to the American College of Radiology (ACR) Appropriateness Criteria, the definitive initial study, Fluoroscopy fistulography hemodialysis access area of interest, is rated Usually Appropriate.

Who Fits This Clinical Scenario for a Non-Maturing Fistula?

This guidance applies specifically to patients with a newly created upper or lower extremity arteriovenous fistula that has failed to mature adequately for hemodialysis within the first 2-3 months post-creation. Maturation failure is typically defined by the “Rule of 6s”: the fistula has not achieved a flow rate of >600 mL/min, a diameter of >6 mm, and is not within 6 mm of the skin surface. The key feature of this scenario is a primary failure of the fistula to develop, rather than a secondary problem in a previously functional access.

This workflow is distinct from other common dialysis access issues. It does not apply to:

  • A mature, previously functional fistula or graft now showing signs of dysfunction. This includes decreased flow rates during dialysis, prolonged bleeding post-cannulation, or high venous pressures. That presentation represents acquired dysfunction, not primary maturation failure.
  • Suspected acute thrombosis of a fistula or graft. A patient presenting with a sudden loss of thrill and pulse in the access requires an urgent evaluation for thrombosis, which is a different clinical pathway.
  • Clinical suspicion of isolated central venous stenosis. While central stenosis can cause maturation failure, a patient presenting primarily with arm or facial swelling points toward a workup focused on the central veins.

Correctly identifying your patient’s presentation as primary maturation failure is critical to selecting the most effective initial imaging test.

What Diagnoses Are You Working Up in This Scenario?

When a new AVF fails to mature, the underlying cause is almost always an anatomic or hemodynamic obstruction that prevents the outflow vein from dilating and arterializing. The imaging workup is designed to identify these specific, and often correctable, lesions.

The most common cause is a juxta-anastomotic stenosis. This is a narrowing that develops in the outflow vein within the first few centimeters of the surgical anastomosis. It is often caused by vessel injury during surgery, intimal hyperplasia, or pre-existing venous abnormalities. This single lesion can severely limit inflow and prevent the entire fistula from developing.

Another frequent culprit is the presence of competing accessory veins. These are side branches off the primary outflow vein that divert a significant portion of the arterial inflow. This “steals” the high-flow volume needed to remodel and dilate the intended fistula vein, causing it to remain small and unusable for dialysis.

Less commonly, the problem may lie further downstream in the form of a more distal outflow vein stenosis or even a central venous stenosis (e.g., in the subclavian vein or brachiocephalic vein). These obstructions increase pressure within the fistula circuit, impeding its development.

Finally, an inflow artery stenosis can also be responsible, though this is a less frequent cause. A significant narrowing in the artery feeding the fistula will limit the volume and pressure of blood entering the circuit, dooming the maturation process from the start.

Why Is Fluoroscopic Fistulography the Recommended First Step?

For a fistula that has failed to mature, direct visualization of the entire vascular circuit is essential for planning intervention. The ACR rates both Fluoroscopy fistulography and US duplex Doppler as Usually Appropriate, but fistulography is often the definitive first step when endovascular therapy is anticipated.

Fluoroscopy fistulography hemodialysis access area of interest provides a dynamic, real-time roadmap of the fistula. By injecting contrast directly into the access, an interventional radiologist can visualize the inflow artery, the anastomosis, the entire length of the outflow vein, and the central veins in a single procedure. This allows for precise identification of stenoses, accessory veins, and other anatomical problems. Crucially, if a correctable lesion is found, percutaneous transluminal angioplasty (ballooning) or coil embolization of competing veins can often be performed during the same session, making it a powerful diagnostic and therapeutic tool. This procedure involves a moderate radiation dose (ACR RRL: ☢☢☢ 1-10 mSv).

US duplex Doppler hemodialysis access area of interest is also Usually Appropriate and is an excellent non-invasive alternative. It uses no radiation (ACR RRL: O 0 mSv) and can measure vessel diameters, assess for stenoses, and calculate blood flow volumes. It is particularly useful for initial non-invasive assessment or for post-intervention surveillance. However, it can be limited by vessel depth, patient body habitus, and its inability to visualize the central veins comprehensively. Often, an abnormal ultrasound will still require a fistulogram for definitive diagnosis and treatment.

Alternative cross-sectional imaging modalities are Usually Not Appropriate.

  • CTA extremity area of interest with IV contrast and CTV extremity area of interest with IV contrast are rated lower because they require a significant intravenous iodinated contrast load, which is undesirable in patients with end-stage renal disease. They also provide static images rather than the dynamic flow information offered by fistulography.
  • MRA/MRV extremity area of interest is also Usually Not Appropriate. The primary concern is the risk of nephrogenic systemic fibrosis (NSF) associated with gadolinium-based contrast agents in patients with poor renal function, although this risk is much lower with modern agents. Furthermore, like CT, it lacks the real-time, interventional capability of fluoroscopy.

Once you’ve decided on fistulography, our protocol guide on related IR access procedures covers key techniques and safety principles. While the guide focuses on central venous access, many of the procedural considerations are relevant. See our guide: IR Central Venous Access (PICC, Tunneled, Port).

What’s Next After Fluoroscopy fistulography hemodialysis access area of interest? Downstream Workflow

The results of the fistulogram directly guide the subsequent management, which is often performed in the same interventional radiology suite. The goal is to correct the anatomical defect and salvage the fistula.

If the study is positive for a juxta-anastomotic or outflow stenosis, the immediate next step is percutaneous transluminal angioplasty (PTA). A balloon catheter is advanced across the narrowed segment and inflated to dilate the vessel. The technical success of this procedure is high and can immediately improve flow through the fistula, placing it back on a path to maturation.

If the study identifies significant accessory or competing veins that are siphoning flow from the main fistula conduit, the next step is transcatheter coil embolization. Small platinum coils are deployed into these side branches to occlude them, redirecting blood flow into the primary fistula vein to promote its dilation.

If the fistulogram is negative and reveals a patent, straight-line flow path without significant stenosis or competing branches, the cause of maturation failure is less clear. This may prompt a re-evaluation with Duplex ultrasound to quantify flow volumes or a surgical consultation to consider issues like an undersized anastomosis or poor arterial inflow that was not appreciated on the fistulogram.

If a central venous stenosis is discovered, the workflow becomes more complex. This finding may require specialized angioplasty with high-pressure balloons or stent placement, and it often carries a poorer long-term prognosis for the access.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup of a non-maturing fistula requires timely and precise action. Be mindful of these common pitfalls:

  • Excessive Delay: Waiting beyond 2-3 months to investigate a non-maturing fistula allows fibrotic stenoses to become more organized and resistant to treatment. Early intervention offers the best chance of salvage.
  • Incomplete Imaging: A fistulogram must evaluate the entire circuit from the inflow artery through the central veins to the right atrium. Failing to image the central veins can miss a critical stenosis that is the true cause of the problem.
  • Relying on Physical Exam Alone: While a poor thrill or pulse is a key indicator, it cannot diagnose the specific underlying problem. Objective imaging is required to plan therapy.
  • Choosing CT or MRI First: Jumping to cross-sectional imaging exposes the patient to unnecessary contrast risks (iodine or gadolinium) and does not offer the therapeutic potential of a fistulogram.

If a fistulogram reveals a complex central venous occlusion or if multiple endovascular attempts to salvage the fistula fail, escalate care by consulting with both vascular surgery and interventional radiology to discuss alternative strategies, including surgical revision or creation of a new access site.

Related ACR Topics and Tools

For a comprehensive overview of all clinical scenarios related to dialysis access imaging, further reading on specific protocols, or to discuss radiation dose with your patients, the following resources are available:

Frequently Asked Questions

What is the difference between ‘failure to mature’ and ‘fistula dysfunction’?

‘Failure to mature’ refers to a newly created arteriovenous fistula (AVF) that never develops the necessary size and flow rate to be used for hemodialysis, typically within the first 2-3 months. ‘Fistula dysfunction’ refers to a previously mature and functional AVF that later develops problems like decreased flow, high venous pressures, or prolonged bleeding.

Can I just start with a Duplex Ultrasound instead of a fistulogram?

Yes, Duplex Ultrasound is also rated ‘Usually Appropriate’ by the ACR and is an excellent non-invasive first step. It can identify many causes of maturation failure, such as stenoses or low flow. However, if an intervention like angioplasty is anticipated, the patient will still need a fistulogram, which serves as both the definitive diagnostic test and the platform for treatment.

What is the ‘Rule of 6s’ for fistula maturation?

The ‘Rule of 6s’ is a clinical guideline used to assess if an arteriovenous fistula is mature enough for cannulation. A mature fistula should ideally have a blood flow rate greater than 600 mL/min, be no more than 6 mm deep from the skin surface, and have a diameter of at least 6 mm.

Is there a role for MRA or CTA if the fistulogram is inconclusive?

Generally, no. For this specific scenario, the ACR rates MRA and CTA as ‘Usually Not Appropriate.’ The risks associated with contrast agents in patients with end-stage renal disease and the lack of dynamic, real-time information make them less suitable than fistulography or ultrasound. If a fistulogram is inconclusive, the next step is more likely to be a repeat ultrasound or surgical consultation rather than cross-sectional imaging.

What are the primary risks of a fistulogram?

A fistulogram is a safe procedure but carries small risks, including bleeding or hematoma at the access site, vessel injury (dissection or rupture) from the catheter or balloon, allergic reaction to the iodinated contrast dye, and radiation exposure (typically 1-10 mSv). The contrast can also be a concern for patients with residual renal function, though this is less of an issue for those already on dialysis.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026